Citations

Citations to this article as recorded by  

• Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis
  Nour Arakil, Shahid Akhtar Akhund, Basant Elaasser, Khalid S. Mohammad
  Biomedicines.2024; 12(5): 1075.     CrossRef
• Germacrone alleviates breast cancer‐associated osteolysis by inhibiting osteoclastogenesis via inhibition of MAPK/NF‐κB signaling pathways
  Zhengjun Lin, Yaocheng Yang, Tang Liu, Ziyi Wu, Xianghong Zhang, Jing Yang
  Phytotherapy Research.2024; 38(6): 2860.     CrossRef
• Acro metastasis: A rare presentation in a common cancer
  Ali Ghanei-Shahmirzadi, Nasrin Namdari, Maral Mokhtari, Pooya Iranpour
  Current Problems in Cancer: Case Reports.2024; 14: 100292.     CrossRef
• Concise review: breast cancer stems cells and their role in metastases
  Mohammad Kamalabadi Farahani, Mohammad Farjadmehr, Amir Atashi, Alireza Momeni, Mahin Behzadifard
  Annals of Medicine & Surgery.2024; 86(9): 5266.     CrossRef
• Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels
  Saptarshi Sinha, Brennan W. Callow, Alex P. Farfel, Suchismita Roy, Siyi Chen, Maria Masotti, Shrila Rajendran, Johanna M. Buschhaus, Celia R. Espinoza, Kathryn E. Luker, Pradipta Ghosh, Gary D. Luker
  Journal of Clinical Investigation.2024;[Epub]     CrossRef
• Management of Oligometastatic Breast Cancer: An Expert Committee’s Opinion
  Dominique Leblanc, Guy Cantin, Alexandra Desnoyers, Jean Dufresne, Giuseppina Laura Masucci, Valérie Panet-Raymond, Éric Poirier, Sara Soldera, Isabelle Gingras
  Current Oncology.2023; 30(2): 1416.     CrossRef
• Surgery in the Setting of Metastatic Breast Cancer
  Jennifer K. Plichta, Mahsa Taskindoust, Rachel A. Greenup
  Current Breast Cancer Reports.2023; 15(1): 37.     CrossRef
• Team Approach: Management of Pathologic Fractures
  Aws Hammad, Osman Ahmed, Philip P. Connell, Daniel Olson, Tessa Balach
  JBJS Reviews.2023;[Epub]     CrossRef
• Diagnostic effectiveness of [18F]Fluoroestradiol PET/CT in oestrogen receptor-positive breast cancer: the key role of histopathology. Evidence from an international multicentre prospective study
  Gianluca Bottoni, Francesco Fiz, Matteo Puntoni, Federica Matteucci, Manuela Monti, Andrea DeCensi, Oriana Nanni, Etienne Brain, Jean Louis Alberini, Bassam Dib, Gianmauro Sacchetti, Pierpaolo Trimboli, Giorgio Treglia, Nadia Harbeck, Simona Sola, Alessan
  European Journal of Nuclear Medicine and Molecular Imaging.2023; 50(8): 2477.     CrossRef
• Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort
  Alexandre Prieur, Andrew Harper, Momtafin Khan, Bérengère Vire, Dominique Joubert, Léa Payen, Karen Kopciuk
  BMC Cancer.2023;[Epub]     CrossRef
• SCUBE2 mediates bone metastasis of luminal breast cancer by modulating immune-suppressive osteoblastic niches
  Qiuyao Wu, Pu Tian, Dasa He, Zhenchang Jia, Yunfei He, Wenqian Luo, Xianzhe Lv, Yuan Wang, Peiyuan Zhang, Yajun Liang, Wenjin Zhao, Jun Qin, Peng Su, Yi-Zhou Jiang, Zhi-Ming Shao, Qifeng Yang, Guohong Hu
  Cell Research.2023; 33(6): 464.     CrossRef
• Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer
  Mónica Cejuela, Ana Gil-Torralvo, M. Ángeles Castilla, M. Ángeles Domínguez-Cejudo, Alejandro Falcón, Marta Benavent, Sonia Molina-Pinelo, Manuel Ruiz-Borrego, Javier Salvador Bofill
  International Journal of Molecular Sciences.2023; 24(10): 8488.     CrossRef
• Multidimensional analysis to elucidate the possible mechanism of bone metastasis in breast cancer
  Kang Yao, Zhu Xiaojun, Zhao Tingxiao, Liao Shiyao, Ji Lichen, Zhang Wei, Li Yanlei, Tian Jinlong, Ding Xiaoyan, Zhang Jun, Bi Qing, Lv Jun
  BMC Cancer.2023;[Epub]     CrossRef
• Diagnostic and Prognostic Role of 18F-Fluoroestradiol PET in Metastatic Breast Cancer: The Second Youth of an Older Theranostic Concept
  Francesco Fiz, Gianluca Bottoni, Giorgio Treglia, Pierpaolo Trimboli, Arnoldo Piccardo
  Journal of Clinical Medicine.2022; 11(13): 3589.     CrossRef
• Prominin 1 Significantly Correlated with Bone Metastasis of Breast Cancer and Influenced the Patient’s Prognosis
  Cheng-cheng Yu, Yi-nan Wu, Kai-min Hu, Su-zhan Zhang, Ali Imran
  BioMed Research International.2022;[Epub]     CrossRef
• Development of local injectable, bone-targeting nanocarriers of triptolide for treatment of bone-only metastasis
  Wucheng Wen, Pengbo Guo, Hui Yi Xue, Ho Lun Wong
  International Journal of Pharmaceutics.2022; 625: 122092.     CrossRef
• Clinical Characteristics, Prognostic Factors and Treatment Outcomes of Patients with Bone-Only Metastatic Breast Cancer
  Lina Marie, Dina Braik, Nayef Abdel-Razeq, Hala Abu-Fares, Ahmad Al-Thunaibat, Hikmat Abdel-Razeq
  Cancer Management and Research.2022; Volume 14: 2519.     CrossRef
• Bone Metastasis of Breast Cancer: Molecular Mechanisms and Therapeutic Strategies
  Lulian Pang, Chen Gan, Jian Xu, Yingxue Jia, Jiaying Chai, Runze Huang, Anlong Li, Han Ge, Sheng Yu, Huaidong Cheng
  Cancers.2022; 14(23): 5727.     CrossRef
• Is there a role for locoregional treatment of the primary tumor in de novo metastatic breast cancer in the era of tailored therapies?
  E. Pons-Tostivint, E. Alouani, Y. Kirova, F. Dalenc, C. Vaysse
  Critical Reviews in Oncology/Hematology.2021; 157: 103146.     CrossRef
• Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO study
  Jae Ho Jeong, Jeong Eun Kim, Jin-Hee Ahn, Kyung Hae Jung, Su-Jin Koh, Jaekyung Cheon, Joohyuk Sohn, Gun Min Kim, Keun Seok Lee, Sung Hoon Sim, In Hae Park, Sung-Bae Kim
  European Journal of Cancer.2021; 144: 341.     CrossRef
• Analysis of genomics and immune infiltration patterns of epithelial-mesenchymal transition related to metastatic breast cancer to bone
  Shuzhong Liu, An Song, Yunxiao Wu, Siyuan Yao, Muchuan Wang, Tong Niu, Chengao Gao, Ziquan Li, Xi Zhou, Zhen Huo, Bo Yang, Yong Liu, Yipeng Wang
  Translational Oncology.2021; 14(2): 100993.     CrossRef
• Trefoil factor-1 upregulation in estrogen-receptor positive breast cancer correlates with an increased risk of bone metastasis
  Chiara Spadazzi, Laura Mercatali, Mark Esposito, Yong Wei, Chiara Liverani, Alessandro De Vita, Giacomo Miserocchi, Elisa Carretta, Michele Zanoni, Claudia Cocchi, Alberto Bongiovanni, Federica Recine, Yibin Kang, Toni Ibrahim
  Bone.2021; 144: 115775.     CrossRef
• Diagnosis and referral of adults with suspected bony metastases
  Samantha Downie, Elizabeth Bryden, Fergus Perks, A Hamish RW Simpson
  BMJ.2021; : n98.     CrossRef
• Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis
  Francesco Schettini, Mario Giuliano, Fabiola Giudici, Benedetta Conte, Pietro De Placido, Sergio Venturini, Carla Rognoni, Angelo Di Leo, Mariavittoria Locci, Guy Jerusalem, Lucia Del Mastro, Fabio Puglisi, PierFranco Conte, Michelino De Laurentiis, Lajos
  Cancers.2021; 13(6): 1458.     CrossRef
• Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT
  Gianluca Bottoni, Arnoldo Piccardo, Francesco Fiz, Giacomo Siri, Federica Matteucci, Andrea Rocca, Oriana Nanni, Manuela Monti, Etienne Brain, Jean Louis Alberini, Bassam Dib, Gian Mauro Sacchetti, Chiara Saggia, Valentina Rossi, Nadia Harbeck, Rachel Wue
  European Journal of Radiology.2021; 141: 109821.     CrossRef
• Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis
  Daniel Reinhorn, Raz Mutai, Rinat Yerushalmi, Assaf Moore, Eitan Amir, Hadar Goldvaser
  The Breast.2021; 58: 173.     CrossRef
• Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer
  Kerui Wu, Jiamei Feng, Feng Lyu, Fei Xing, Sambad Sharma, Yin Liu, Shih-Ying Wu, Dan Zhao, Abhishek Tyagi, Ravindra Pramod Deshpande, Xinhong Pei, Marco Gabril Ruiz, Hiroyuki Takahashi, Shunsuke Tsuzuki, Takahiro Kimura, Yin-yuan Mo, Yusuke Shiozawa, Ravi
  Nature Communications.2021;[Epub]     CrossRef
• Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?
  Adam S. Komorowski, Ellen Warner, Helen J. MacKay, Arjun Sahgal, Kathleen I. Pritchard, Katarzyna J. Jerzak
  Clinical Breast Cancer.2020; 20(1): e54.     CrossRef
• Radiation therapy for bone-only metastases in breast cancer patients: A GOCO survey of current clinical practice
  Marta Bonet, Virginia García, Núria Farré, Manel Algara, Blanca Farrús, Jaume Fernandez, Victoria Reyes, Arancha Eraso, Ana Álvarez, Maria José Cambra, Agustí Pedro, Jordi Vayreda, Claire Lemansky, Françoise Izar, Meritxell Arenas
  Reports of Practical Oncology & Radiotherapy.2020; 25(1): 113.     CrossRef
• MicroRNA-429 inhibits bone metastasis in breast cancer by regulating CrkL and MMP-9
  Xinxin Zhang, Xiying Yu, Zhenguo Zhao, Zhennan Yuan, Peiqing Ma, Zhibin Ye, Liping Guo, Songfeng Xu, Libin Xu, Ting Liu, Huanmei Liu, Shengji Yu
  Bone.2020; 130: 115139.     CrossRef
• Metastatic Presentations of Previously Treated Early-Stage Breast Cancer Patients and Association With Survival
  Najla Itani, Nicole Grogan, Sarah Mott, Sneha Phadke
  Clinical Breast Cancer.2020; 20(3): 209.     CrossRef
• Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer
  Cynthia Huang Bartlett, Jack Mardekian, Matthew James Cotter, Xin Huang, Zhe Zhang, Christina M. Parrinello, Ariel Bulua Bourla, Apar Kishor Ganti
  PLOS ONE.2020; 15(4): e0227256.     CrossRef
• International Framework for Red Flags for Potential Serious Spinal Pathologies
  Laura M. Finucane, Aron Downie, Christopher Mercer, Susan M. Greenhalgh, William G. Boissonnault, Annelies L. Pool-Goudzwaard, Jason M. Beneciuk, Rachel L. Leech, James Selfe
  Journal of Orthopaedic & Sports Physical Therapy.2020; 50(7): 350.     CrossRef
• Prognostic Value of Modified IHC4 Score in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer
  Liang Jin, Kai Chen, Cui Tan, Jianbin Li, Jiayue Luo, Yaping Yang, Yudong Li, Shunying Li, Liling Zhu, Yue Hu, Fengtao Liu, Qiuting You, Min Peng, Zefei Jiang, Qiang Liu
  The Oncologist.2020; 25(8): e1170.     CrossRef
• Imaging diagnosis of metastatic breast cancer
  Filippo Pesapane, Kate Downey, Anna Rotili, Enrico Cassano, Dow-Mu Koh
  Insights into Imaging.2020;[Epub]     CrossRef
• Tamoxifen Rechallenge Decreases Metastatic Potential but Increases Cell Viability and Clonogenicity in a Tamoxifen-Mediated Cytotoxicity-Resistant Subline of Human Breast MCF7 Cancer Cells
  Yung-Chieh Chang, Chun Hei Antonio Cheung, Yao-Lung Kuo
  Frontiers in Cell and Developmental Biology.2020;[Epub]     CrossRef
• Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials
  Richard S. Finn, Massimo Cristofanilli, Johannes Ettl, Karen A. Gelmon, Marco Colleoni, Carla Giorgetti, Eric Gauthier, Yuan Liu, Dongrui R. Lu, Zhe Zhang, Cynthia Huang Bartlett, Dennis J. Slamon, Nicholas C. Turner, Hope S. Rugo
  Breast Cancer Research and Treatment.2020; 184(1): 23.     CrossRef
• Innovative Options for Bone Metastasis Treatment: An Extensive Analysis on Biomaterials-Based Strategies for Orthopedic Surgeons
  Ania Naila Guerrieri, Monica Montesi, Simone Sprio, Roberta Laranga, Laura Mercatali, Anna Tampieri, Davide Maria Donati, Enrico Lucarelli
  Frontiers in Bioengineering and Biotechnology.2020;[Epub]     CrossRef
• The influence of breast cancer subtype on survival after palliative radiation for osseous metastases
  Mohamed K. Abdelhakiem, Candice Johnstone, Carmen Bergom, Adam Currey, Jared R. Robbins
  Cancer Medicine.2020; 9(23): 8979.     CrossRef
• Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics
  Jin-Xiao Ren, Yue Gong, Hong Ling, Xin Hu, Zhi-Ming Shao
  Breast Cancer Research and Treatment.2019; 173(1): 225.     CrossRef
• Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study
  Kang Wang, Yang Shi, Zhu-Yue Li, Ye-Lei Xiao, Jie Li, Xiang Zhang, Hong-Yuan Li
  European Journal of Surgical Oncology.2019; 45(8): 1364.     CrossRef
• The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis
  Ricardo Romero-Moreno, Kimberly J. Curtis, Thomas R. Coughlin, Maria Cristina Miranda-Vergara, Shourik Dutta, Aishwarya Natarajan, Beth A. Facchine, Kristen M. Jackson, Lukas Nystrom, Jun Li, William Kaliney, Glen L. Niebur, Laurie E. Littlepage
  Nature Communications.2019;[Epub]     CrossRef
• Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study
  Guenther G. Steger, Adriana Dominguez, Natalia Dobrovolskaya, Francesco Giotta, Nicole Tubiana-Mathieu, Martin Pecherstorfer, Antonio Ardizzoia, Maria Blasinska-Morawiec, Enrique Espinosa, Gustavo Villanova
  Clinical Breast Cancer.2018; 18(1): e41.     CrossRef
• Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990–2010
  Judith A. Malmgren, Musa Mayer, Mary K. Atwood, Henry G. Kaplan
  Breast Cancer Research and Treatment.2018; 167(2): 579.     CrossRef
• Breast cancer bone metastases: pathogenesis and therapeutic targets
  Naomi Brook, Emily Brook, Arun Dharmarajan, Crispin R. Dass, Arlene Chan
  The International Journal of Biochemistry & Cell Biology.2018; 96: 63.     CrossRef
• Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data
  Hongwei Zhang, Wei Zhu, Ewelina Biskup, Weige Yang, Ziang Yang, Hong Wang, Xiaochun Qiu, Chengjiao Zhang, Guangxia Hu, Guangfu Hu
  Journal of Bone Oncology.2018; 11: 38.     CrossRef
• Breast osteoblast-like cells: a new biomarker for the management of breast cancer
  Manuel Scimeca, Nicoletta Urbano, Rita Bonfiglio, Orazio Schillaci, Elena Bonanno
  British Journal of Cancer.2018; 119(9): 1129.     CrossRef
• Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer
  Akiko Ogiya, Kieko Yamazaki, Rie Horii, Tadahiko Shien, Yoshiya Horimoto, Norikazu Masuda, Touko Inao, Mitsuchika Hosoda, Naoko Ishida, Tomofumi Osako, Masato Takahashi, Yumi Endo, Yuichiro Miyoshi, Hiroyuki Yasojima, Nobumoto Tomioka, Hiroko Yamashita
  Breast Cancer.2017; 24(3): 473.     CrossRef
• Pattern of metastatic spread and subcategories of breast cancer
  Catharina Bartmann, Manfred Wischnewsky, Tanja Stüber, Roland Stein, Mathias Krockenberger, Sebastian Häusler, Wolfgang Janni, Rolf Kreienberg, Maria Blettner, Lukas Schwentner, Achim Wöckel, Joachim Diessner
  Archives of Gynecology and Obstetrics.2017; 295(1): 211.     CrossRef
• Osteonecrosis of the Jaw in a Breast Cancer Patient Treated with Everolimus and a Single Dose of Zoledronic Acid
  Claudia Omarini, Maria E. Filieri, Roberta Depenni, Giulia Grizzi, Stefano Cascinu, Federico Piacentini
  The Breast Journal.2017; 23(5): 610.     CrossRef
• The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone
  Aurélie Bellanger, Caterina F Donini, Julie A Vendrell, Jonathan Lavaud, Irma Machuca‐Gayet, Maëva Ruel, Julien Vollaire, Evelyne Grisard, Balázs Győrffy, Ivan Bièche, Olivier Peyruchaud, Jean‐Luc Coll, Isabelle Treilleux, Véronique Maguer‐Satta, Véroniqu
  The Journal of Pathology.2017; 242(1): 73.     CrossRef
• Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis
  I Bado, Z Gugala, S A W Fuqua, X H-F Zhang
  Oncogene.2017; 36(32): 4527.     CrossRef
• Which red flags aid the early detection of metastatic bone disease in back pain?
  Laura Finucane, Susan Greenhalgh, James Selfe
  Physiotherapy Practice and Research.2017; 38(2): 73.     CrossRef
• Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis
  Soyeon Park, Joon-Kee Yoon, Su Jin Lee, Seok Yun Kang, Hyunee Yim, Young-Sil An
  Medicine.2017; 96(50): e8985.     CrossRef
• Tolerability of Therapies Recommended for the Treatment of Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer
  Shinji Ohno
  Clinical Breast Cancer.2016; 16(4): 238.     CrossRef
• Quality of life and symptom burden in patients with metastatic breast cancer
  Christine Ecclestone, Ronald Chow, Natalie Pulenzas, Liying Zhang, Angela Leahey, Julia Hamer, Carlo DeAngelis, Gillian Bedard, Rachel McDonald, Anchal Bhatia, Janet Ellis, Eileen Rakovitch, Sherlyn Vuong, Edward Chow, Sunil Verma
  Supportive Care in Cancer.2016; 24(9): 4035.     CrossRef
• Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer
  Joachim Diessner, Manfred Wischnewsky, Tanja Stüber, Roland Stein, Mathias Krockenberger, Sebastian Häusler, Wolfgang Janni, Rolf Kreienberg, Maria Blettner, Lukas Schwentner, Achim Wöckel, Catharina Bartmann
  BMC Cancer.2016;[Epub]     CrossRef
• Prolactin receptor in breast cancer: marker for metastatic risk
  Carrie S Shemanko
  Journal of Molecular Endocrinology.2016; 57(4): R153.     CrossRef
• Clinical Characteristics and Outcome of Bone-Only Metastasis in Inflammatory and Noninflammatory Breast Cancers
  Megumi Kai, Takahiro Kogawa, Diane D. Liu, Tamer M. Fouad, Kazuharu Kai, Naoki Niikura, Limin Hsu, Jie S. Willey, Richard L. Theriault, Vicente Valero, Naoto T. Ueno
  Clinical Breast Cancer.2015; 15(1): 37.     CrossRef
• Loading Dose Ibandronate Versus Standard Oral Ibandronate in Patients With Bone Metastases From Breast Cancer
  Iain R. Macpherson, Caroline Bray, Carol Hopkins, Rosemary A. Hannon, Liz-Anne Lewsley, Diana M. Ritchie, Peter Canney
  Clinical Breast Cancer.2015; 15(2): 117.     CrossRef
• Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care?
  D.K. Woolf, A.R. Padhani, A. Makris
  Annals of Oncology.2015; 26(6): 1048.     CrossRef
• Survival time according to the year of recurrence and subtype in recurrent breast cancer
  Masahiro Nakano, Mamiko Fujisue, Rumiko Tashima, Yasuhiro Okumura, Yasuyuki Nishiyama, Tomofumi Ohsako, Yasuo Toyozumi, Nobuyuki Arima, Reiki Nishimura
  The Breast.2015; 24(5): 588.     CrossRef
• Cases of Bone-only Metastasis in Recurrent Breast Cancer
  Yoko MAEKAWA, Shintaro TAKAO, Koichi HIROKAGA, Mayuko MIKI, Sachiko YOSHIDA
  Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2014; 75(6): 1484.     CrossRef
• Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors
  June Koo Lee, Seock-Ah Im, Daewon Lee, Ji-Yeon Kim, Yoojoo Lim, Eunyoung Lee, Hyeong-Gon Moon, Tae-Yong Kim, Sae-Won Han, Do-Youn Oh, Se-Hoon Lee, Wonshik Han, Dong-Wan Kim, Tae-You Kim, Dong-Young Noh
  Journal of Breast Cancer.2013; 16(1): 66.     CrossRef
• Incidence, consequences and treatment of bone metastases in breast cancer patients—Experience from a single cancer centre
  I. Kuchuk, B. Hutton, P. Moretto, T. Ng, C.L. Addison, M. Clemons
  Journal of Bone Oncology.2013; 2(4): 137.     CrossRef
• Zooming in on the schedule of bone-modifying drugs
  Miguel Martin, Sara López-Tarruella
  The Lancet Oncology.2013; 14(7): 575.     CrossRef
• Bone metastases: assessment, management and treatment options
  Carole Farrell
  British Journal of Nursing.2013; 22(Sup7): S4.     CrossRef
• Limites de la scintigraphie osseuse dans le suivi des métastases osseuses du carcinome mammaire : étude du centre tunisien
  K. Chatti, A. Harrabi, I. Chabchoub, T. Kamoun, R. Sfar, M. Nouira, M.B. Fredj, N. Ayachi, S.B. Ahmed, H. Essabbah
  Médecine Nucléaire.2012; 36(10): 574.     CrossRef

Citations

Citations to this article as recorded by  

• circ_HMGCS1 modulates hepatocellular carcinoma chemoresistance via miR‐338‐5p/IL‐7 pathway
  Siyu Zhang, Jun Ma, Tingdong Yu, Zhengrui Song, Wan Yee Lau, Yong Zha
  Journal of Cellular and Molecular Medicine.2024;[Epub]     CrossRef
• Inhibition of mycobacteria proliferation in macrophages by low cisplatin concentration through phosphorylated p53-related apoptosis pathway
  Jiajia Bao, Yonglin He, Chun Yang, Nan Lu, Anlong Li, Sijia Gao, Felycia Fernanda Hosyanto, Jialing Tang, Junzhuo Si, Xia Tang, Huichao Fu, Lei Xu, Harish Chandra
  PLOS ONE.2023; 18(1): e0281170.     CrossRef
• A clinical trial with valproic acid and hydralazine in combination with gemcitabine and cisplatin followed by doxorubicin and dacarbazine for advanced hepatocellular carcinoma
  Yao‐Chung Liu, Chien‐Wei Su, Po‐Shen Ko, Rheun‐Chuan Lee, Chia‐Jen Liu, Yi‐Hsiang Huang, Jyh‐Pyng Gau, Jin‐Hwang Liu
  Asia-Pacific Journal of Clinical Oncology.2022; 18(1): 19.     CrossRef
• A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and 90Y-loaded glass microsphere selective internal radiation therapy
  Vincent Manceau, Xavier Palard, Yan Rolland, March Pracht, Samuel Le Sourd, Sophie Laffont, Karim Boudjema, Astride Lievre, Habiba Mesbah, Laure-Anne Haumont, Laurence Lenoir, Vanessa Brun, Thomas Uguen, Julien Edeline, Etienne Garin
  European Journal of Nuclear Medicine and Molecular Imaging.2018; 45(10): 1731.     CrossRef
• Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1
  Jun Qin, Meng Luo, Haixin Qian, Wei Chen
  Gene.2014; 538(2): 342.     CrossRef
• The effects of fucodian on senescence are controlled by the p16INK4a-pRb and p14Arf-p53 pathways in hepatocellular carcinoma and hepatic cell lines
  EUN-YOUNG MIN, IN-HYE KIM, JUNGIM LEE, EUN-YOUNG KIM, YOUN-HEE CHOI, TAEK-JEONG NAM
  International Journal of Oncology.2014; 45(1): 47.     CrossRef
• The flavonoids diosmetin and luteolin exert synergistic cytostatic effects in human hepatoma HepG2 cells via CYP1A-catalyzed metabolism, activation of JNK and ERK and P53/P21 up-regulation
  Vasilis P. Androutsopoulos, Demetrios A. Spandidos
  The Journal of Nutritional Biochemistry.2013; 24(2): 496.     CrossRef
• Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan
  Hiroki Nishikawa, Yukio Osaki, Ryuichi Kita, Toru Kimura
  Cancers.2012; 4(1): 165.     CrossRef